TABLE 8.
Estimates of genetic correlations ± standard errors for complete blood count (CBC) traits that showed significant differences among groups with the resilience traits of grow-to-finish growth rate (GFGR) and treatment rate (TR).
| Traits1 | GFGR | TR |
| Blood3 | ||
| LYM | 0.10 ± 0.18 | −0.38 ± 0.182 |
| RDW | −0.07 ± 0.21 | 0.39 ± 0.22 |
| MPV | 0.09 ± 0.18 | 0.26 ± 0.18 |
| Blood4 | ||
| NEU | −0.31 ± 0.20 | 0.50 ± 0.23 |
| LYM | 0.16 ± 0.15 | −0.28 ± 0.16 |
| RBC | 0.15 ± 0.15 | −0.08 ± 0.17 |
| HGB | 0.04 ± 0.16 | −0.25 ± 0.18 |
| HCT | 0.10 ± 0.17 | −0.33 ± 0.19 |
| MCV | −0.08 ± 0.15 | −0.16 ± 0.16 |
| MCH | −0.03 ± 0.14 | −0.21 ± 0.15 |
| RDW | −0.12 ± 0.28 | 0.89 ± 0.26 |
| MPV | 0.09 ± 0.17 | 0.11 ± 0.19 |
| Δ133 | ||
| LYM | 0.15 ± 0.23 | −0.46 ± 0.24 |
| MCHC | −0.25 ± 0.20 | 0.26 ± 0.21 |
| Δ344 | ||
| NEU | −0.45 ± 0.21 | 0.44 ± 0.26 |
| RBC | −0.33 ± 0.45 | −0.35 ± 0.43 |
| HGB | 0.01 ± 0.25 | −0.32 ± 0.28 |
| HCT | −0.29 ± 0.44 | −0.82 ± 0.47 |
| MCV | 0.03 ± 0.19 | 0.02 ± 0.20 |
| MCH | 0.25 ± 0.25 | 0.14 ± 0.28 |
| MPV | −0.15 ± 0.26 | −0.27 ± 0.28 |
| Δ145 | ||
| NEU | −0.32 ± 0.26 | 0.76 ± 0.29 |
| MCV | 0.02 ± 0.33 | −0.02 ± 0.35 |
| MCH | 0.00 ± 0.35 | 0.26 ± 0.36 |
1NEU: neutrophil concentration; LYM: lymphocyte concentration; MONO: monocyte concentration; RBC: red blood cell concentration; HGB: hemoglobin concentration; HCT: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW: red blood cell distribution width. 2Significant estimates of genetic correlations are highlighted in bold based on the likelihood ratio test by comparing full models to restricted models that constrained the genetic covariance to zero in ASReml 4.1 (p < 0.05). 3The change of CBC traits from Blood 1 to Blood 3; 4The change of CBC traits from Blood 3 to Blood 4; 5The change of CBC traits from Blood 1 to Blood 4.